Teva Pharmaceuticals USA Inc recalls Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles, Rx Only, Manufactured by: Actavi
Recalled August 10, 2022 · FDA recall D-1303-2022 · Teva Pharmaceuticals USA
Hazard
Failed Dissolution Specifications: below specification limits for dissolution. · FDA Class II
Units
5677 bottles
Sold at
Nationwide in the USA and Puerto Rico
Description
Failed Dissolution Specifications: below specification limits for dissolution.
Product
Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL USA 33314, USA, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054 USA; NDC 58544-692-30.
Manufacturer(s)
Teva Pharmaceuticals USA Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →